The molecular geography of cell signaling diseases
Molecular Pharmacology · 2026
DOI: 10.1016/j.molpha.2026.100151 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Pharmacology, 2026. Verfasst von John D Scott und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, University of Washington School of Medicine, Seattle, Washington. Electronic address: scottjdw@uw.edu. Hauptthemen laut MEDLINE: Signal Transduction, A Kinase Anchor Proteins. Die Arbeit nennt 85 Literaturangaben. Gefördert von: National Institute of Neurological Disorders and Stroke, National Institute of General Medical Sciences, Fibrolamellar Cancer Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, University of Washington School of Medicine, Seattle, Washington. Electronic address: scottjdw@uw.edu.
- Department of Integrative Biology and Pharmacology, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, Texas.
Förderung
- National Institute of Neurological Disorders and Stroke
- National Institute of General Medical Sciences
- Fibrolamellar Cancer Foundation
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases Division of Diabetes Endocrinology and Metabolic Diseases
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Scott, J. D., & Dessauer, C. W. (2026). The molecular geography of cell signaling diseases. Molecular Pharmacology. https://doi.org/10.1016/j.molpha.2026.100151
Vancouver
Scott JD, Dessauer CW. The molecular geography of cell signaling diseases. Molecular Pharmacology. 2026. doi:10.1016/j.molpha.2026.100151
BibTeX
@article{Scott2026,
author = {Scott, John D and Dessauer, Carmen W},
title = {The molecular geography of cell signaling diseases},
journal = {Molecular Pharmacology},
year = {2026},
doi = {10.1016/j.molpha.2026.100151}
}
EUVIMED